Nexalin Technology, Inc. 10-Q

Item 5. Other Information None . 34 Item 6. Exhibits (a) Exhibits. 1.1 (2) Underwriting Agreement dated as of September 15, 2022 between the Company and Maxim Group LLC 1.2 (11) Equity Distribution Agreement between the Company and Maxim Group LLC 1.3 (12) Underwriting Agreement dated May 4, 2025 between the Company and Maxim Group LLC 3.1 (1) Certificate of Incorporation, as amended and as currently in effect. 3.2 (1) Amended and Restated Bylaws 4.1 (1) Form of Specimen stock certificate evidencing shares of common stock 4.2 (3) Warrant Agreement between the Company and Continental Stock Transfer and Trust company as warrant agent dated as of September 16, 2022 4.3 (3) Form of Warrant Certificate (filed as part of Exhibit 4.2) 10.1 (5) Joint Venture Agreement between the Company and Wider Come Limited dated as of May 31, 2023. 10.2 (5) Employment Agreement between the Company and Mark White dated as of July 1, 2023. 10.3 (5) Services Agreement between the Company and David Owens, M.D. dated as of July 1, 2023. 10.4 (1) Quality Assurance Agreement between the Company and Apical Instruments dated December 31, 2020. 10.5 (1) Advisor Agreement with Leonard Osser dated as of December 22,2021 10.6 (1) Advisor Agreement with Tucker Anderson dated as of December 24, 2021 10.7 (1) Advisor Agreement with Gian Domenico Trombetta dated December 24, 2021 10.8 (1) Employment Agreement between the Company and Marilyn Elson dated as of January 11, 2022 10.9 (1) Amendment and Deferral Agreement dated as of March 30, 2022 to Consulting Agreement between the Company and US Asian Consulting Group LLC 10.10 (5) Employment Agreement between the Company and Michael Nketiah dated as of July 1, 2023. 10.11 (1) Form of Lock-Up Agreement. 10.12 (1) Consulting Agreement dated as of May 9, 2018 between the Company and US Asian Consulting Group, LLC, as amended on January 2, 1019 and March 4, 2021 10.13 (4) Amended and Restated Promissory Note in favor Mark White dated as of January 1, 2023 10.14 (1) Distribution Authorization Agreement dated as of May 1, 2019 with Wider Come Limited. 10.15 (6) Form of Lock-Up Agreement 10.16 (6) Form of Securities Purchase Agreement 10.17 (7) Placement Agency Agreement 10.18 (8) Letter Agreement between the Company and Carolyn Shelton 10.19 (9) Supplier Quality Agreement dated as of December 20, 2024 between the Company and Velentium 19.1 (10) Nexalin Technology, Inc. Insider Trading Policy 31.1 (13) Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended 32.1 (13) Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 35 97.1 (10) Nexalin Technology, Inc. Compensation Recoupment Policy 99.1 (1) Code of Ethics 99.2 (1) Audit Committee Charter 99.3 (1) Compensation Committee Charter 99.4 (1) Nominating and Corporate Governance Committee Charter (1) Previously filed as an exhibit to Form S-1 as declared effective by the SEC on September 15, 2022 (SEC File Number 333-261989). (2) Previously filed as an exhibit to Form 8-K as filed with the SEC on September 20, 2022. (3) Previously filed as an exhibit to Form 8-K/A as filed with the SEC on September 20, 2022. (4) Previously filed as an exhibit to Form 10-Q as filed with the SEC on May 10, 2023. (5) Previously filed as an exhibit to Form 10-Q as filed with the SEC on August 10, 2023. (6) Previously filed as an exhibit to Form S-1/A as declared effective by the SEC on June 27, 2024 (SEC File Number 333-279684). (7) Previously filed as an exhibit to Form 8-K as filed with the SEC on July 3, 2024. (8) Previously filed as an exhibit to Form 8-K as filed with the SEC on September 19, 2024. (9) Previously filed as an exhibit to Form S-1/A as filed with the SEC on January 30, 2025 (SEC File Number 333-283960). (10) Previously filed as an exhibit to Form 10-K/A as filed with the SEC on April 15, 2025. (11) Filed as an exhibit to Form S-3 as declared effective by the SEC on April 29, 2025 (SEC File No. 333-286711). (12) Previously filed as an exhibit to Form 8-K as filed with the SEC on May 6, 2025. (13) Filed as an exhibit to this Form 10-Q. 36 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 10-Q to be signed on its behalf by the undersigned thereunto duly authorized on the 13th day of May, 2025. NEXALIN TECHNOLOGY, INC. By: /s/ Mark White Mark White Chief Executive Officer Principal Executive Officer Principal Financial Officer 37